Institutional investors purchased a net $87.7 thousand shares of CGIX during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 11.74% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 133.7 Thousand shares of Cancer Genetics Inc
JACOBS LEVY EQUITY MANAGEMENT, I... Bought 116.4 Thousand shares of Cancer Genetics Inc
WEDBUSH SECURITIES, INC. Bought 90.5 Thousand shares of Cancer Genetics Inc